IndiaOne Finance - Company Dashboard

Governance Classic Home

Themis Medicare LtdPharmaceuticalsINE083B01024Consolidated₹123.97+4.12 (+3.44%)Jun-26

Valuation

Market Cap₹1.14K Cr

TTM PE28.56x

Forward PE19.66x

PEG0.01

Book Value₹43.28

P/B2.86x

TTM EPS₹4.34

Fwd EPS₹6.31

TTM Revenue₹331.61 Cr

TTM PAT₹39.97 Cr

TTM EBITDA₹-41.95 Cr

TTM EBIT₹-52.26 Cr

Last Qtr PAT₹24.61 Cr

Last Qtr EBITDA₹-52.42 Cr

Last Qtr EBIT₹-54.96 Cr

Profitability

ROE10.03%

ROCE10.87%

TTM NPM12.05%

TTM EBITDA %-12.65%

Curr OPM27.98%

Last OPM11.08%

Curr NPM—

Last NPM—

Curr EPS₹2.67

Last EPS₹0.96

Balance sheet

Equity₹9.21 Cr

Reserve₹389.37 Cr

Total Debt₹100.09 Cr

D/E0.25x

Interest %12.11%

Curr Interest₹2.98 Cr

Price / range

Close₹123.97

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+3.44%

1W-3.34%

1M+16.06%

3M+21.77%

6M+59.84%

1Y-5.89%

2Y-52.05%

3Y-27.78%

5Y+22.55%

Diwali+24.22%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	86.96-10.9%	76.53	90.13	77.99	97.58	342.24
Other Income	0.99	3.67	1.28	3.24	1.18	9.36
Total Income	87.95-10.9%	80.20	91.42	81.23	98.75	351.60
Interest	2.98	2.70	2.75	2.77	2.47	10.69
Expenditure	-144.90-28.6%	-78.06	-85.68	-86.42	-112.68	-362.84
PBDT	0	0	0	0	0	0
EBITDA	-52.42-420.0%	3.77	9.79	-3.08	-10.08	0.41
Depreciation	-2.54	-2.60	-2.59	-2.58	-2.55	-10.32
EBIT	-54.96-335.2%	1.17	7.20	-5.66	-12.63	-9.91
PBT	42.72+380.7%	2.14	4.87	-5.19	-15.22	-13.40
Tax	-13.99	-0.17	-0.29	-0.17	-0.16	-0.78
Equity	9.21	9.21	0	0	9.20	9.21
OPM	48.57	2.67	5.41	-6.66	-15.41	-3.81
Net Profit	28.74+287.0%	1.97	4.58	-5.36	-15.37	-14.19
NPM	32.68	2.46	5.08	-6.87	-15.56	-4.03
EPS	3.12+286.8%	0.21	0.50	-0.58	-1.67	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	342.24-15.6%	405.51+6.2%	381.76+7.7%	354.32-10.2%	394.61+71.1%	230.67
Other Income	9.36	4.67	4.76	11.51	6.54	3.62
Total Income	351.60-14.3%	410.18+6.1%	386.52+5.7%	365.83-8.8%	401.16+71.2%	234.29
Expenditure	-362.84+3.6%	-376.42-7.0%	-351.85-14.6%	-306.92+3.2%	-317.22-57.0%	-202.04
Interest	-10.69	-10.04	-9.38	-9.56	-8.77	-12.71
PBDT	0	0	0	0	0	0
EBITDA	0.41-99.2%	49.06-4.8%	51.54-23.6%	67.46-29.5%	95.64+91.7%	49.89
Depreciation	-10.32	-9.93	-12.25	-10.50	-9.48	-8.55
EBIT	-9.91-125.3%	39.13-0.4%	39.29-31.0%	56.96-33.9%	86.16+108.4%	41.34
PBT	-13.40-139.7%	33.76-2.6%	34.67-41.1%	58.91-29.8%	83.94+160.3%	32.25
Tax	-0.78	-9.84	-9.92	-15.61	-22.38	-5.63
Equity	9.21	9.20	0	0	0	0
OPM (%)	-3.81	8.23	9.00	16.00	21.00	14.00
Net Profit	-14.19-159.3%	23.92-3.4%	24.75-42.8%	43.30-29.7%	61.56+131.3%	26.62
NPM (%)	-4.03	5.83	6.00	12.00	15.00	11.00
EPS (Rs)	0-100.0%	2.60-3.3%	2.69-94.3%	47.05-29.7%	66.91+131.0%	28.97
CEPS	0	2.59	2.68	46.97	66.78	28.96

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	86.96-10.9%	76.53	90.13	77.99	97.58	342.24
Other Income	0.99	3.67	1.28	3.24	1.18	9.36
Total Income	87.95-10.9%	80.20	91.42	81.23	98.75	351.60
Interest	2.98	2.70	2.75	2.77	2.47	10.69
Expenditure	-144.90-28.6%	-78.07	-85.68	-86.42	-112.68	-362.85
PBDT	0	0	0	0	0	0
EBITDA	-52.42-420.0%	3.76	9.79	-3.08	-10.08	0.40
Depreciation	-2.54	-2.60	-2.59	-2.58	-2.55	-10.32
EBIT	-54.96-335.2%	1.16	7.20	-5.66	-12.63	-9.92
PBT	36.01+358.5%	2.13	4.87	0	-13.93	-12.12
Tax	-13.99	-0.17	-0.29	-0.17	-0.16	-0.78
Equity	9.21	9.21	0	0	9.20	9.21
OPM	40.94	2.66	5.33	0.00	-14.11	-3.45
Net Profit	24.61+273.1%	8.89	10.09	-3.62	-14.22	1.14
NPM	27.98	11.08	11.04	-4.45	-14.40	0.33
EPS	2.67+273.4%	0.96	1.10	-0.39	-1.54	0.12

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	342.24-15.6%	405.51+6.2%	381.76+7.7%	354.32-10.2%	394.61+71.1%	230.67
Other Income	9.36	4.67	4.76	11.51	6.54	3.62
Total Income	351.60-14.3%	410.18+6.1%	386.52+5.7%	365.83-8.8%	401.16+71.2%	234.29
Expenditure	-362.85+3.6%	-376.43-7.0%	-351.88-14.6%	-306.93+3.2%	-317.23-56.7%	-202.44
Interest	-10.69	-10.04	-9.38	-9.56	-8.78	-12.71
PBDT	0	0	0	0	0	0
EBITDA	0.40-99.2%	49.05-4.8%	51.51-23.6%	67.45-29.5%	95.64+93.3%	49.49
Depreciation	-10.32	-9.93	-12.25	-10.50	-9.48	-8.55
EBIT	-9.92-125.4%	39.12-0.4%	39.26-31.1%	56.95-33.9%	86.16+110.5%	40.94
PBT	-12.12-135.9%	33.75-2.6%	34.64-41.2%	58.90-29.8%	83.92+163.4%	31.86
Tax	-0.78	-9.84	-9.92	-15.61	-22.38	-5.63
Equity	9.21	9.20	0	0	0	0
OPM (%)	-3.45	8.23	8.96	16.10	20.92	13.60
Net Profit	1.14-96.2%	29.83-31.5%	43.52-23.5%	56.90-21.9%	72.88+104.1%	35.70
NPM (%)	0.33	7.27	11.26	15.55	18.17	15.24
EPS (Rs)	0.12-96.3%	3.24-31.5%	4.73-92.3%	61.83-22.0%	79.22+103.9%	38.86
CEPS	0.12	3.24	4.72	61.73	79.07	38.84

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	0.5	04 Sep 2025
2024	Final Dividend	0.5	12 Jul 2024
2023	Final Dividend	5	01 Sep 2023
2022	Final Dividend	5	08 Sep 2022
2021	Final Dividend	4.3	08 Sep 2021
2020	Final Dividend	1.75	17 Sep 2020
2011	Final Dividend	3	20 Jul 2011
2010	Final Dividend	3	16 Jun 2010
2008	Final Dividend	2.5	01 Aug 2008

Bonus

No bonus history.

Split

Year	Ratio	Ex-Date
2023	Rs.10/- to Rs.1/-	10 Oct 2023

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split